newsfilter
← Latest News
GlobeNewswire·

Galecto Announces Pricing of $275 Million Underwritten Public Offering

BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers, today